Zografos, Eleni
Korakiti, Anna-Maria
Andrikopoulou, Angeliki
Rellias, Ioannis
Dimitrakakis, Constantine
Marinopoulos, Spyridon
Giannos, Aris
Keramopoulos, Antonios
Bredakis, Nikolaos
Dimopoulos, Meletios-Athanasios
Zagouri, Flora
Article History
Received: 27 February 2021
Accepted: 30 April 2021
First Online: 19 May 2021
Declarations
:
: The present study was performed in accordance to the ethical standards of the institution and followed the tenets of the Helsinki Declaration; ethics approval was granted by the Institutional Review Board of the Alexandra Hospital in Athens, Greece, and written informed consent was obtained from all participants.
: Not applicable.
: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: FZ has received honoraria for lectures and has served in an advisory role for Astra-Zeneca, Daiichi, Eli-Lilly, Merck, Novartis, Pfizer, and Roche. MAD has received honoraria from participation in advisory boards from Amgen, Bristol-Myers-Squibb, Celgene, Janssen, Takeda. The remaining authors (EZ, AMK, AA, IR, CD, SM, AG, AK, and NB) declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as potential conflict of interest.